Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.30 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2892232 | 0.80 | CSNK2A1 (0.36) | CSNK2A1NPSR1CSNK2A2CSNK2B | |
| SCHEMBL12173291 | 0.70 | CSNK2A1 (0.31) | CSNK2A1NPSR1CSNK2A2CSNK2B | |
| SCHEMBL8628938 | 0.68 | CSNK2A1 (0.30) | CSNK2A1NPSR1CSNK2A2CSNK2B | |
| SCHEMBL12764905 | 0.68 | L3MBTL1 (0.31) | CSNK2A1NPSR1CSNK2A2CSNK2B | |
| SCHEMBL12438043 | 0.65 | — | — | |
| SCHEMBL11334722 | 0.65 | — | — | |
| SCHEMBL11690249 | 0.64 | L3MBTL1 (0.42) | — | |
| SCHEMBL22750777 | 0.64 | — | — | |
| SCHEMBL13762293 | 0.62 | — | — | |
| SCHEMBL22750757 | 0.61 | CTH (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120232285-A1 | Sulfonyl-1,2,4-triazole salts | UNIVERSITE DE MONTREAL (CA) | 2012-09-13 | — | — | US | disclosed |
| US-7271228-B2 | Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts | ACEP INC. (CA) | 2007-09-18 | — | — | US | disclosed |
| US-20050266289-A1 | Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts | ACEP INC. (CA) | 2005-12-01 | — | — | US | disclosed |
| US-6858691-B2 | Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts | ACEP INC. (CA) | 2005-02-22 | — | — | US | disclosed |
| EP-0968196-B1 | PERFLUOROVINYL IONIC COMPOUNDS AND THEIR USE IN CONDUCTIVE MATERIALS | ACEP INC (CA) | 2004-10-27 | — | — | EP | disclosed |
| US-20040023092-A1 | Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts | ACEP INC. (CA) | 2004-02-05 | — | — | US | disclosed |
| US-6593019-B2 | Ionically conducting materials, electrolytes and selective membranes | ACEP INC. (CA) | 2003-07-15 | — | — | US | disclosed |
| US-20020193540-A1 | Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts | ARMAND MICHEL (CA) | 2002-12-19 | — | — | US | disclosed |
| US-6426397-B1 | Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts | ACEP INC. (CA) | 2002-07-30 | — | — | US | disclosed |
| US-20020026021-A1 | Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts | ARMAND MICHEL (CA) | 2002-02-28 | — | — | US | disclosed |
| US-6288187-B1 | CROSSLINKED ANIONIC POLYMER; ELECTROLYTES; PERMSELECTIVE MEMBRANES | ACEP INC. (CA) | 2001-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120232285-A1 | Sulfonyl-1,2,4-triazole salts | STS, TST, FIS1 | CSNK2A1 1747/4885NPSR1 2758/4885CSNK2A2 1832/4885 |
| US-20020193540-A1 | Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts | CCNO, SCO2, CNR2 | CSNK2A1 350/4885NPSR1 695/4885CSNK2A2 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.